Delving Into Device Data: FDA's Epidemiology Network Is Taking Shape
This article was originally published in The Gray Sheet
Executive Summary
FDA's new device epidemiology network, aimed at improving device surveillance, should be fully up and running this fall.
You may also be interested in...
CDRH Seeks To Expand Public-Private Medical Device Epidemiology Network
FDA hopes the MDEpiNet post-market surveillance program will be fully functional by the end of the year. A May public meeting is planned to catalyze the effort.
User Fee Negotiators Far Apart: Industry Seeks To Delay New Fee Levels Until FDA Improves Performance
Device industry reps say industry-paid FDA user fees should be reauthorized for only two years, not five, to allow ongoing changes to FDA's pre-market review programs to sink in before a more meaningful user fee package is passed.
User Fee Negotiators Far Apart: Industry Seeks To Delay New Fee Levels Until FDA Improves Performance
Device industry reps say industry-paid FDA user fees should be reauthorized for only two years, not five, to allow ongoing changes to FDA's pre-market review programs to sink in before a more meaningful user fee package is passed.